Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 10—October 2021
Research

Direct and Indirect Effectiveness of mRNA Vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 in Long-Term Care Facilities, Spain

Susana MongeComments to Author , Carmen Olmedo, Belén Alejos, María Fé Lapeña, María José Sierra1, Aurora Limia1, and COVID-19 Registries Study Group2
Author affiliation: Ministry of Health, Madrid, Spain

Main Article

Figure 1

Seven-day cumulative incidence of diagnosis of severe acute respiratory syndrome coronavirus 2, Spain. Shadowed areas indicate the study period for the selected persons (December 27, 2020–March 10, 2021) and the reference period 87 days before (October 1–December 13, 2020).

Figure 1. Seven-day cumulative incidence of diagnosis of severe acute respiratory syndrome coronavirus 2, Spain. Shadowed areas indicate the study period for the selected persons (December 27, 2020–March 10, 2021) and the reference period 87 days before (October 1–December 13, 2020).

Main Article

1These senior authors contributed equally to this article.

2Group members are listed at the end of this article.

Page created: July 20, 2021
Page updated: September 19, 2021
Page reviewed: September 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external